Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
26.01
-0.33 (-1.25%)
At close: Dec 16, 2025, 4:00 PM EST
26.00
-0.01 (-0.04%)
After-hours: Dec 16, 2025, 7:39 PM EST
Progyny Market Cap
Progyny has a market cap or net worth of $2.24 billion as of December 16, 2025. Its market cap has increased by 69.13% in one year.
Market Cap
2.24B
Enterprise Value
1.93B
1-Year Change
69.13%
Ranking
Category
Stock Price
$26.01
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.24B, an increase of 71.19%. That is a compound annual growth rate of 9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 2.24B | 52.66% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 949.11B |
| Johnson & Johnson | 516.58B |
| AbbVie | 401.02B |
| UnitedHealth Group | 309.54B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.08B |
| Novo Nordisk | 224.22B |